glp-1 regulatory news obesity drug today september 22 2025 drugs are already famous for weight loss glp-1 regulatory news GLP-1 Agonists

But there are risks to any medication

Studies using monoclonal antibodies against GLP-1R revealed that it is mainly present in the vasculature of the kidney (Ronn et al., 2017)

I.UdellJ

It also modulates extracellular matrix turnover by restoring the balance between metalloproteinases (MMPs) and their tissue inhibitors (TIMPs)

As optometrists, we must be mindful of any potential adverse effects our patients medications might have on their overall health and/or on their existing health conditions

Research focuses on maintaining a youthful cellular profile, protecting tissues from catabolism, and influencing lipid metabolism (promoting lipolysis and reducing visceral fat)